Unknown

Dataset Information

0

Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial.

ABSTRACT:

SUBMITTER: Welsh SE 

PROVIDER: S-EPMC8248080 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Transcriptomics Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial
2019-06-29 | GSE133477 | GEO
Unknown Itch in Atopic Dermatitis - What Is New?
| S-EPMC8137993 | biostudies-literature
Transcriptomics A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis
2018-10-06 | GSE120899 | GEO
Unknown Neuroimmune interactions in chronic itch of atopic dermatitis.
| S-EPMC7027518 | biostudies-literature
Unknown Brain Processing of Contagious Itch in Patients with Atopic Dermatitis.
| S-EPMC5524890 | biostudies-other
Unknown The imagined itch: brain circuitry supporting nocebo-induced itch in atopic dermatitis patients.
| S-EPMC4609272 | biostudies-literature
Unknown Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.
| S-EPMC8372662 | biostudies-literature
Unknown Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation.
| S-EPMC7247952 | biostudies-literature
Unknown Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis.
| S-EPMC6884397 | biostudies-literature
Unknown The Pathology of Type 2 Inflammation-Associated Itch in Atopic Dermatitis.
| S-EPMC8618746 | biostudies-literature